logo

For the Inventor, By the Inventor

Cambridge, MA, United States of America

Syndevrx, Inc.

Calculating rank
USPTO Granted Patents = 19


Trademarks = 3

Forward Citations = 114

Loading Chart...
Loading Chart...

3 inventors (with patents filed for the assignee):

goldMedal John S Petersen (15 out of 40 patents)

silverMedal James Shanahan (11 out of 11 patents)

bronzeMedal Peter Cornelius (4 out of 8 patents)


19 patents:

1. 12419846 - Biomarkers of METAP2 inhibitors and applications thereof (2025-09-23),
2. 11612577 - Biomarkers of METAP2 inhibitors and applications thereof (2023-03-28),
3. 11304944 - MetAP2 inhibitors and methods of treating obesity (2022-04-19),
4. 11273142 - Treatment for tumors driven by metabolic dysfunction (2022-03-15),
5. 10722532 - Polymer-conjugated METAP2 inhibitors, and therapeutic methods of use thereof (2020-07-28),
6. 10646463 - Treatment for tumors driven by metabolic dysfunction (2020-05-12),
7. 10588904 - METAP2 inhibitors and methods of treating obesity (2020-03-17),
8. 10287277 - Fumagillol derivatives and polymorphs thereof (2019-05-14),
9. 10159692 - Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof (2018-12-25),
10. 10010544 - METAP2 inhibitors and methods of treating obesity (2018-07-03),
11. 9969722 - Fumagillol derivatives and polymorphs thereof (2018-05-15),
12. 9895449 - Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof (2018-02-20),
13. 9757373 - MetAP2 inhibitors and methods of treating obesity (2017-09-12),
14. 9750737 - METAP2 inhibitors and methods of treating obesity (2017-09-05),
15. 9730955 - Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof (2017-08-15),
Company Overview
Syndevrx, Inc. is a biotechnology company based in Cambridge, MA, specializing in the development of innovative therapeutic solutions. The organization focuses on advancing drug discovery and development processes, particularly in the fields of precision medicine and targeted therapies. By leveraging cutting-edge research and technology, Syndevrx aims to address unmet medical needs and improve patient outcomes through its specialized expertise in molecular biology and pharmacology.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

Syndevrx, Inc. USPTO Patent Assignee Logo
19 Patents

#145 in Cambridge, MA

#1,049 in Massachusetts

#17,154 in US

#32,705 in the World

Cambridge, MA (US)
Cambridge, MA, United States of America

Syndevrx, Inc.

Forward Citations = 114

3 inventors:

goldMedal John S Petersen (15 out of 40 patents)

silverMedal James Shanahan (11 out of 11 patents)

bronzeMedal Peter Cornelius (4 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Syndevrx, Inc.. Retrieved from https://idiyas.com/company/syndevrx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…